European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea.

Randerath, Winfried; Verbraecken, Johan; de Raaff, Christel A L; Hedner, Jan; Herkenrath, Simon; Hohenhorst, Winfried; Jakob, Tina; Marrone, Oreste; Marklund, Marie; McNicholas, Walter T; Morgan, Rebecca L; Pepin, Jean-Louis; Schiza, Sofia; Skoetz, Nicole; Smyth, Dan; Steier, Jörg; Tonia, Thomy; Trzepizur, Wojciech; van Mechelen, Piet-Heijn and Wijkstra, Peter (2021). European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea. European respiratory review, 30(162), p. 210200. European Respiratory Society 10.1183/16000617.0200-2021

Preview

Text Randerath_EurRespirRev_2021.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (655kB) | Preview

Treatment of obstructive sleep apnoea (OSA) in adults is evolving, as new therapies have been explored and introduced in clinical practice, while other approaches have been refined or reconsidered. In this European Respiratory Society (ERS) guideline on non-continuous positive airway pressure (CPAP) therapies for OSA, we present recommendations determined by a systematic review of the literature. It is an update of the 2011 ERS statement on non-CPAP therapies, advanced into a clinical guideline. A multidisciplinary group of experts, including pulmonary, surgical, dentistry and ear-nose-throat specialists, methodologists and patient representatives considered the most relevant clinical questions (for both clinicians and patients) relating to the management of OSA. Eight key clinical questions were generated and a systematic review was conducted to identify published randomised clinical trials that answered these questions. We used the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to assess the quality of the evidence and the strength of recommendations. The resulting guideline addresses gastric bypass surgery, custom-made dual-block mandibular advancement devices, hypoglossal nerve stimulation, myofunctional therapy, maxillo-mandibular osteotomy, carbonic anhydrase inhibitors and positional therapy. These recommendations can be used to benchmark quality of care for people with OSA across Europe and to improve outcomes.

Interest & Impact

Downloads

42 since deposited on 10 Dec 2021
35 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item